(Q38093867)

28 August 2017

Oxidative-stress-induced epigenetic changes in chronic diabetic complications (English)

1 reference

28 August 2017

Biao Feng

1

1 reference

PubMed ID

23537434

28 August 2017

Michael Anthony Ruiz

series ordinal

2

1 reference

PubMed ID

23537434

28 August 2017

Subrata Chakrabarti

series ordinal

3

1 reference

28 August 2017

17 December 2012

1 reference

Canadian Journal of Physiology and Pharmacology

28 August 2017

1 reference

28 August 2017

91

1 reference

28 August 2017

3

1 reference

28 August 2017

213-220

1 reference

Reactive oxygen and nitrogen species in pathogenesis of vascular complications of diabetes

28 August 2017

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

MicroRNA-133 controls cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

The magic and mystery of microRNA-27 in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Endothelium-specific SIRT1 overexpression inhibits hyperglycemia-induced upregulation of vascular cell senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Oxidative stress-induced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Epigenetics: mechanisms and implications for diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Regulated nucleosome mobility and the histone code.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

How the diabetic eye loses vision.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Clinical significance of inflammatory and fibrogenic cytokines in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Curcumin--from molecule to biological function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

miR-320 Regulates Glucose-Induced Gene Expression in Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

miR133a regulates cardiomyocyte hypertrophy in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Most mammalian mRNAs are conserved targets of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Oxidative stress in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Histone deacetylases--an important class of cellular regulators with a variety of functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Altered MAPK signaling in progressive deterioration of endothelial function in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Auto-acetylation stabilizes p300 in cardiac myocytes during acute oxidative stress, promoting STAT3 accumulation and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Diabetes complications: the microRNA perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Diabetic nephropathy: mechanisms of renal disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-{beta}-induced collagen expression in kidney cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Diabetes-induced extracellular matrix protein expression is mediated by transcription coactivator p300

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Functional siRNAs and miRNAs Exhibit Strand Bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

MicroRNA biogenesis: coordinated cropping and dicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

NF-kappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Suppression of NF-κB and NF-κB regulated oxidative stress and neuroinflammation by BAY 11-7082 (IκB phosphorylation inhibitor) in experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Living in a box or call of the wild? Revisiting lifetime inactivity and sarcopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Synthesis, crystal structure and anti-inflammatory properties of curcumin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Inhibition of LPS-induced production of inflammatory factors in the macrophages by mono-carbonyl analogues of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Leptin and endothelin-1 mediated increased extracellular matrix protein production and cardiomyocyte hypertrophy in diabetic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Diabetic cardiomyopathy: pathophysiology and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

DNA methylation: the nuts and bolts of repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

At the crossroad of lifespan, calorie restriction, chromatin and disease: meeting on sirtuins

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Nrf2 and NF-κB modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

The role of oxidative stress in diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Increased breath biomarkers of oxidative stress in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Diabetic neuropathy: clinical features, etiology, and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Role of forkhead transcription factors in diabetes-induced oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Genome regulation by long noncoding RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

MicroRNAs in metabolism and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: focus on functional, sensorimotor and biochemical changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

MicroRNAs 103 and 107 regulate insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Control of translation and mRNA degradation by miRNAs and siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Genotoxic stress and activation of novel DNA repair enzymes in human endothelial cells and in the retinas and kidneys of streptozotocin diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

MicroRNAs in insulin resistance and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

PARP activation and the alteration of vasoactive factors and extracellular matrix protein in retina and kidney in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Sirtuin 1-mediated cellular metabolic memory of high glucose via the LKB1/AMPK/ROS pathway and therapeutic effects of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0251

21 January 2018

Identifiers

DOI

10.1139/CJPP-2012-0251

1 reference

28 August 2017

1 reference

PubMed ID

23537434